go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

Grunenthal Ltd

Grunenthal Ltd
4045 Kingswood Road, Citywest Business Park, Citywest, Co Dublin, Ireland
Telephone: +44 (0)870 351 8960
Medical Information Direct Line: +44 (0)870 351 8960
Medical Information e-mail: medicalinformationie@grunenthal.com
Summary of Product Characteristics last updated on medicines.ie: 25/05/2010
SPC Zydol 100mg Solution for Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 25/05/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.2 - Posology and method of administration
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   30-Apr-2010
Legal Category:   Product subject to medical prescription which may not be renewed (A)

Free-text change information supplied by the pharmaceutical company

In Section 4.2, the dosage in Children above the age of 1 year has been updated with supporting data.
In Section 10, the approval date has been updated.
Updated on 02/11/2009 and displayed until 25/05/2010
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   19-Oct-2009
Legal Category:   Product subject to medical prescription which may be renewed (B)

Free-text change information supplied by the pharmaceutical company


Section 4.8 Undesirable effects
'Speech disorders' and 'mydriasis' have been added to Nervous system disorders and Eye disorders, respectively. 'CNS symptoms' (i.e. confusion, delusions, depersonalisation, derealisation, paranoia) has been updated with examples in General disorders.  
The frequencies in the section have been re-formatted.
 
2. Section 10 Date of Revision of the text
Approval date ' October 2009' has been included.
Updated on 24/02/2009 and displayed until 02/11/2009
Reasons for adding or updating:
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   01/2009
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

update date to: January 2009

Updated on 04/02/2009 and displayed until 24/02/2009
Reasons for adding or updating:
  • Change to section 4.9 - Overdose
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   11/2008
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

4.9       Overdose  
Advice on how to treat cases of overdose and cases of intoxication with tramadol.

10.       DATE OF REVISION OF THE TEXT

 Date updated to November 2008

Updated on 26/11/2008 and displayed until 04/02/2009
Reasons for adding or updating:
  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 7 - Marketing authorisation holder
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   04/2008
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

section 1  clarification of 100 mg / 2 ml
 section 2  clarification of 100 mg / 2 ml
 section 3 clarification that the product is a Solution for injection
 section 4.6 typographic
 section 7 formatting
 section 9 addition date information
 section 10 data update
Updated on 31/05/2007 and displayed until 26/11/2008
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose
  • Change to section 5.3 - Preclinical safety data
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 10 - Date of revision of the text
  • Change to section 5.1 - Pharmacodynamic properties
Date of revision of text on the SPC:   04/2007
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

Section 2 – format/harmonisation of text and additional information on excipients

  Section 4.1 – format/harmonisation of text

  Section 4.2 - – format/harmonisation, change in children age limit

  Section 4.3 - – format/harmonisation of text

  Section 4.4 – format/harmonisation of text

  Section 4.5 – format/harmonisation, INR warning updated, additional information

  Section 4.6 – format/harmonisation of text

  Section 4.7– format/harmonisation of text

  Section 4.8 – format/harmonisation including additions and deletion of adverse reaction details

  Section 4.9 – format/harmonisation with addition advice.

  Section 5.1 – format/harmonisation of text

  Section 5.3 – format/harmonisation of text

  Section 6.6 – format/harmonisation

  Section 10 – updated date of SPC

Updated on 24/07/2006 and displayed until 31/05/2007
Reasons for adding or updating:
  • Change to section 4.1 - Therapeutic indications
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   06/2006
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

 

          section 4.1  - indication change to state' Management of moderate to severe pain.'

          section 10 - date of revision

Updated on 07/06/2006 and displayed until 24/07/2006
Reasons for adding or updating:
  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 4 - Clinical particulars
  • Change to section 5 - Pharmacological properties
  • Change to section 6 - Pharmaceutical particulars
  • Change to section 7 - Marketing authorisation holder
  • Change to section 8 - MA number
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text
Updated on 03/11/2005 and displayed until 07/06/2006
Reasons for adding or updating:
  • New SPC for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Tramadol Hydrochloride

Versions

 
25/05/2010 to Current
02/11/2009 to 25/05/2010
24/02/2009 to 02/11/2009
04/02/2009 to 24/02/2009
26/11/2008 to 04/02/2009
31/05/2007 to 26/11/2008
24/07/2006 to 31/05/2007
07/06/2006 to 24/07/2006
03/11/2005 to 07/06/2006
  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo